| Followers | 129 |
| Posts | 2150 |
| Boards Moderated | 1 |
| Alias Born | 12/27/2007 |
Tuesday, January 28, 2020 3:44:24 PM
BXRX =Mcap $82 M- FDA DECISION ON FEB.20 --Could run to $20 and more ahead of the potential FDA approval
BXRX =MC $82 M -Cash $20 M- Shares Out 9 M / FDA DECISION ON FEB.20 for Non-Opioid Pain Drug / UNKNOWN Gem = 500%+ Upside
Baudax Bio,(BXRX) a specialty pharmaceutical company focused on therapeutics for acute care settings, today announced that the U.S. Food and Drug Administration (FDA) has set a PDUFA goal date of February 20, 2020 for its decision on the New Drug Application (NDA) for intravenous (IV) meloxicam for the management of moderate to severe pain.
BXRX =MC $82 M -Cash $20 M- Shares Out 9 M / FDA DECISION ON FEB.20 for Non-Opioid Pain Drug / UNKNOWN Gem = 500%+ Upside
Baudax Bio,(BXRX) a specialty pharmaceutical company focused on therapeutics for acute care settings, today announced that the U.S. Food and Drug Administration (FDA) has set a PDUFA goal date of February 20, 2020 for its decision on the New Drug Application (NDA) for intravenous (IV) meloxicam for the management of moderate to severe pain.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
